Slide 100002-E-1 – 1 December 2003 Anti-HIV drugs 2010-2011 Andrea De Luca, M.D. Institute of Clinical Infectious Diseases. Catholic University, Rome 2nd Division of Infectious…

1.Listening to Consumers in a Highly Regulated EnvironmentHow Pharmaceutical Manufacturers Can Leverage Consumer-Generated Media Melissa DaviesResearch Director, HealthcareNielsen…

1. Innovative Strategies for the Management
 of HIV Infection" Dual therapies without NRTIs Jean-Guy Baril, MD Clinique médicale du Quartier Latin CHUM This activity…

Slide 1 1 Efficacy and safety of switching from boosted Lopinavir (LPV/r) to boosted Atazanavir (ATV/r) in patients with virologic suppression receiving a LPV/r containing…

Slide 1 Treatment of Hepatitis C in patients with thalassaemia. Where are we now? Telaprevir and boceprevir harbingers of important treatment advance Improved response rates…

The Intervention Program A basic principle âHelp your doctor help youâ medAmigo intervention program medAmigo med=medicine, Amigo=Friend medAmigo patient management model…

Effects of Patient Tracking Systems and Providers Incentives on Patient Appointment Keeping Rwanda Pilot Study Report Nyamusore Jose1*, Hinda Ruton1, Mutabazi Vincent1, Karema…

HLA Testing: A Single Centre Experience Laura Waters, Andrea Gritz, Desmond Maitland, Brian Gazzard & Mark Nelson. Research Fellow PKR/SSR St. Stephenâs Centre Chelsea…

Effects of Patient Tracking Systems and Providers Incentives on Patient Appointment Keeping Rwanda Pilot Study Report Nyamusore Jose1*, Hinda Ruton1, Mutabazi Vincent1, Karema…

JEAN-GUY BARIL MD CLINIQUE MÃDICALE DU QUARTIER LATIN CHUM Innovative Strategies for the Management of HIV Infection Dual therapies without NRTIs Jean-Guy Baril, MD Clinique…